Long-term survival in unfavourable-risk mRCC patients after intratumoral administration of a cell-based allogeneic vaccine
Alex Karlsson-Parra, Anna Laurell, Maria Lönnemark, Einar Brekkan, AnnaCarin Wallgren, Anders Magnusson
Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P438; DOI: 10.1186/2051-1426-3-S2-P438
